PMID- 37107928
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230430
IS  - 2227-9032 (Print)
IS  - 2227-9032 (Electronic)
IS  - 2227-9032 (Linking)
VI  - 11
IP  - 8
DP  - 2023 Apr 11
TI  - The Use of Cardioprotective Devices and Strategies in Patients Undergoing 
      Percutaneous Procedures and Cardiac Surgery.
LID - 10.3390/healthcare11081094 [doi]
LID - 1094
AB  - In the United States, about one million people are seen to visit the operating 
      theater for cardiac surgery annually. However, nearly half of these visits result 
      in complications such as renal, neurological, and cardiac injury of varying 
      degrees. Historically, many mechanisms and approaches have been explored in 
      attempts to reduce injuries associated with cardiac surgery and percutaneous 
      procedures. Devices such as cardioplegia, mechanical circulatory support, and 
      other methods have shown promising results in managing and preventing 
      life-threatening cardiac-surgery-related outcomes such as heart failure and 
      cardiogenic shock. Comparably, cardioprotective devices such as TandemHeart, 
      Impella family devices, and venoarterial extracorporeal membrane oxygenation 
      (VA-ECMO) have also been proven to show significant cardioprotection through 
      mechanical support. However, their use as interventional agents in the prevention 
      of hemodynamic changes due to cardiac surgery or percutaneous interventions has 
      been correlated with adverse effects. This can lead to a rebound increased risk 
      of mortality in high-risk patients who undergo cardiac surgery. Further research 
      is necessary to delineate and stratify patients into appropriate cardioprotective 
      device groups. Furthermore, the use of one device over another in terms of 
      efficacy remains controversial and further research is necessary to assess device 
      potential in different settings. Clinical research is also needed regarding novel 
      strategies and targets, such as transcutaneous vagus stimulation and 
      supersaturated oxygen therapy, aimed at reducing mortality among high-risk 
      cardiac surgery patients. This review explores the recent advances regarding the 
      use of cardioprotective devices in patients undergoing percutaneous procedures 
      and cardiac surgery.
FAU - Abdul-Rahman, Toufik
AU  - Abdul-Rahman T
AUID- ORCID: 0000-0003-0153-287X
AD  - Medical Institute, Sumy State University, 40007 Sumy, Ukraine.
AD  - Department of Cardiology, Otto Von Guericke University of Magdeburg, 39120 
      Magdeburg, Germany.
FAU - Lizano-Jubert, Ileana
AU  - Lizano-Jubert I
AUID- ORCID: 0000-0002-9334-1343
AD  - Centro de Investigacion en Ciencias de la Salud (CICSA), FCS, Universidad Anahuac 
      Campus Norte, Huixquilucan 52786, Mexico.
FAU - Garg, Neil
AU  - Garg N
AD  - Rowan-Virtua School of Osteopathic Medicine, One Medical Center Drive Stratford, 
      Stratford, NJ 08084, USA.
FAU - Tejerina-Marion, Emilio
AU  - Tejerina-Marion E
AUID- ORCID: 0009-0002-7009-3102
AD  - Centro de Investigacion en Ciencias de la Salud (CICSA), FCS, Universidad Anahuac 
      Campus Norte, Huixquilucan 52786, Mexico.
FAU - Awais Bukhari, Syed Muhammad
AU  - Awais Bukhari SM
AUID- ORCID: 0000-0002-2295-1048
AD  - Department of Medicine, Nishtar Medical University, Multan 60000, Pakistan.
FAU - Luisa Ek, Ana
AU  - Luisa Ek A
AUID- ORCID: 0009-0005-4589-1999
AD  - Centro de Investigacion en Ciencias de la Salud (CICSA), FCS, Universidad Anahuac 
      Campus Norte, Huixquilucan 52786, Mexico.
FAU - Wireko, Andrew Awuah
AU  - Wireko AA
AD  - Medical Institute, Sumy State University, 40007 Sumy, Ukraine.
AD  - Department of Cardiology, Otto Von Guericke University of Magdeburg, 39120 
      Magdeburg, Germany.
FAU - Mares, Adriana C
AU  - Mares AC
AUID- ORCID: 0000-0003-3870-6263
AD  - Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center 
      El Paso, El Paso, TX 79905, USA.
FAU - Sikora, Vladyslav
AU  - Sikora V
AUID- ORCID: 0000-0002-4147-6879
AD  - Medical Institute, Sumy State University, 40007 Sumy, Ukraine.
AD  - Department of Clinical and Experimental Medicine, University of Foggia, Via 
      Napoli, 20, 71122 Foggia, Italy.
FAU - Gupta, Rahul
AU  - Gupta R
AUID- ORCID: 0000-0002-2511-2119
AD  - Department of Cardiology, Lehigh Valley Health Network, Allentown, PA 18103, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230411
PL  - Switzerland
TA  - Healthcare (Basel)
JT  - Healthcare (Basel, Switzerland)
JID - 101666525
PMC - PMC10137626
OTO - NOTNLM
OT  - cardiac surgery
OT  - ischemia-reperfusion injury
OT  - ventricular assist devices
COIS- The authors declare no conflict of interest.
EDAT- 2023/04/28 06:41
MHDA- 2023/04/28 06:42
PMCR- 2023/04/11
CRDT- 2023/04/28 01:24
PHST- 2023/02/01 00:00 [received]
PHST- 2023/02/28 00:00 [revised]
PHST- 2023/04/06 00:00 [accepted]
PHST- 2023/04/28 06:42 [medline]
PHST- 2023/04/28 06:41 [pubmed]
PHST- 2023/04/28 01:24 [entrez]
PHST- 2023/04/11 00:00 [pmc-release]
AID - healthcare11081094 [pii]
AID - healthcare-11-01094 [pii]
AID - 10.3390/healthcare11081094 [doi]
PST - epublish
SO  - Healthcare (Basel). 2023 Apr 11;11(8):1094. doi: 10.3390/healthcare11081094.